Anzeige
Mehr »
Dienstag, 19.05.2026 - Börsentäglich über 12.000 News
1.700% Preisexplosion: Wird dieser US-Wolfram-Nanocap jetzt neu bewertet?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoGSK signs agreement with Protas to streamline clinical trials
MoRegeneron agrees research collaboration with Parabilis Medicines
FrAstronauTx appoints Michelle Mellion as Chief Medical Officer
FrUS FDA approves Taiho's Inqovi for older adults with acute myeloid leukaemia
DoLilly and UNICEF collaborate to improve non-communicable disease prevention
DoZeno appoints Cendrine Seror as Head of Health, Europe
MiAbbVie Appoints Kelly Sanderson Schrems as UK VP and General Manager
MiBoehringer and Immunitas agree on licensing deal for chronic inflammatory and autoimmune diseases
12.05.Novartis breaks ground on US radioligand therapy site
12.05.OVID Health has appointed Davide Scalenghe as Head of Global Strategy & Partnerships
11.05.LEO Pharma to acquire Replay gene therapy platform
11.05.Cue Biopharma appoints Shao-Lee Lin as CEO, President and Director
08.05.Legend Biotech appoints new group of scientific advisors
07.05.Lilly commits additional $4.5bn for US manufacturing sites
07.05.Langland appoints Victoria Kent as Managing Partner, Medical Strategy & Education
06.05.FDA gives Rare Paediatric Disease designation to Satellite Bio for urea cycle disorders
06.05.GC Therapeutics appoints Stefan Irion as Chief Scientific Officer
05.05.adelo acquires Dot I/O Health, with Nigel Breakwell becoming Managing Partner
05.05.Innovative Trials appoints Anita Owen as first COO
01.05.UCB presentation highlights impacts of epilepsy on daily life
01.05.Inventiva appoints Axel-Sven Malkomes as Chief Financial Officer
30.04.Biogen agrees $850m felzartamab rights deal with TJ Biopharma
30.04.myTomorrows partners with Rare Disease Research to boost rare disease referrals
29.04.Helus Pharma appoints Ken Kramer as Senior VP, Medical Affairs
29.04.Why the field is critical tonext-generation marketing